These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21481042)

  • 1. From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives.
    Sokal EM
    Cell Prolif; 2011 Apr; 44 Suppl 1(Suppl 1):39-43. PubMed ID: 21481042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine.
    Lee CA; Sinha S; Fitzpatrick E; Dhawan A
    J Mol Med (Berl); 2018 Jun; 96(6):469-481. PubMed ID: 29691598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and future challenges in stem cell-derived liver technologies.
    Dalgetty DM; Medine CN; Iredale JP; Hay DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G241-8. PubMed ID: 19520740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of stem cells in liver disease.
    Flohr TR; Bonatti H; Brayman KL; Pruett TL
    Curr Opin Organ Transplant; 2009 Feb; 14(1):64-71. PubMed ID: 19337149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells for end stage liver disease: how far have we got?
    Lorenzini S; Gitto S; Grandini E; Andreone P; Bernardi M
    World J Gastroenterol; 2008 Aug; 14(29):4593-9. PubMed ID: 18698672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular therapy for liver disease.
    Huebert RC; Rakela J
    Mayo Clin Proc; 2014 Mar; 89(3):414-24. PubMed ID: 24582199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Regeneration and Cell Transplantation for End-Stage Liver Disease.
    Li Y; Lu L; Cai X
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases.
    Lee CW; Chen YF; Wu HH; Lee OK
    Gastroenterology; 2018 Jan; 154(1):46-56. PubMed ID: 29107021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regeneration of the liver: from hepatocyte cells to deficient hepatic cells].
    Sokal EM
    Bull Mem Acad R Med Belg; 2009; 164(5-6):207-12; discussion 213. PubMed ID: 20666150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.
    Nicolas CT; Hickey RD; Chen HS; Mao SA; Lopera Higuita M; Wang Y; Nyberg SL
    Stem Cells; 2017 Jan; 35(1):42-50. PubMed ID: 27641427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Kuo TK; Hung SP; Chuang CH; Chen CT; Shih YR; Fang SC; Yang VW; Lee OK
    Gastroenterology; 2008 Jun; 134(7):2111-21, 2121.e1-3. PubMed ID: 18455168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentials of regenerative medicine for liver disease.
    Ogawa S; Miyagawa S
    Surg Today; 2009; 39(12):1019-25. PubMed ID: 19997795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver regenerative medicine: advances and challenges.
    Chistiakov DA
    Cells Tissues Organs; 2012; 196(4):291-312. PubMed ID: 22572238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions and the Emerging Role of the Foetal Liver into Regenerative Medicine.
    Giancotti A; Monti M; Nevi L; Safarikia S; D’Ambrosio V; Brunelli R; Pajno C; Corno S; Di Donato V; Musella A; Chiappetta MF; Bosco D; Panici PB; Alvaro D; Cardinale V
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.
    Cantz T; Sharma AD; Ott M
    Stem Cells; 2015 Apr; 33(4):1055-62. PubMed ID: 25524146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.
    Manzini BM; da Silva Santos Duarte A; Sankaramanivel S; Ramos AL; Latuf-Filho P; Escanhoela C; Kharmandayan P; Olalla Saad ST; Boin I; Malheiros Luzo ÂC
    Cytotherapy; 2015 Aug; 17(8):1052-65. PubMed ID: 26139545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte cell therapy in liver disease.
    Bartlett DC; Newsome PN
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1261-72. PubMed ID: 26212798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell-based regenerative opportunities for the liver: State of the art and beyond.
    Tsolaki E; Yannaki E
    World J Gastroenterol; 2015 Nov; 21(43):12334-50. PubMed ID: 26604641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
    Hansel MC; Davila JC; Vosough M; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Strom SC
    Curr Protoc Toxicol; 2016 Feb; 67():14.13.1-14.13.27. PubMed ID: 26828329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative medicine: a reality of stem cell technology.
    Terzic A; Edwards BS; McKee KC; Nelson TJ
    Minn Med; 2011 May; 94(5):44-7. PubMed ID: 21707014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.